Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial

July 25, 2005

By Jennifer Boggs

Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial

July 25, 2005

By Jennifer Boggs

Dendreon Rises On Provenge Survival Data; Considers BLA

July 22, 2005

By Jennifer Boggs

Dendreon Rises On Provenge Survival Data; Considers BLA

July 22, 2005

By Jennifer Boggs

EPIX's Phase II Trial Delayed For Blood Clot Imaging Agent

July 21, 2005

By Jennifer Boggs

EPIX's Phase II Trial Delayed For Blood Clot Imaging Agent

July 21, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 21, 2025.
Coinfections and diversity paint the many shades of HIV cure
BioWorld
We all look different to HIV, a virus that destroys the immune system. The defensive cells record every interaction with foreign agents, infections from viruses...
Livzon’s IL-17A/F meets phase III endpoints in plaque psoriasis
BioWorld
Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted...
Sino to acquire Lanova and pipeline for up to $950M
BioWorld Asia
Sino Biopharmaceutical Ltd. agreed to fully acquire Lanova Medicines Ltd. by buying an additional 95.09% stake in Lanova at a valuation of up to $950.92 million....